201 related articles for article (PubMed ID: 26539823)
1. Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1.
Renga B; Cipriani S; Carino A; Simonetti M; Zampella A; Fiorucci S
PLoS One; 2015; 10(11):e0141082. PubMed ID: 26539823
[TBL] [Abstract][Full Text] [Related]
2. Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension.
Fiorucci S; Distrutti E
Pharmacol Res; 2016 Sep; 111():749-756. PubMed ID: 27475883
[TBL] [Abstract][Full Text] [Related]
3. Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids.
Renga B; Bucci M; Cipriani S; Carino A; Monti MC; Zampella A; Gargiulo A; d'Emmanuele di Villa Bianca R; Distrutti E; Fiorucci S
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H114-26. PubMed ID: 25934094
[TBL] [Abstract][Full Text] [Related]
4. Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators.
Fiorucci S; Zampella A; Cirino G; Bucci M; Distrutti E
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H21-H32. PubMed ID: 27765751
[TBL] [Abstract][Full Text] [Related]
5. Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.
Carino A; Marchianò S; Biagioli M; Bucci M; Vellecco V; Brancaleone V; Fiorucci C; Zampella A; Monti MC; Distrutti E; Fiorucci S
FASEB J; 2019 Feb; 33(2):2809-2822. PubMed ID: 30303744
[TBL] [Abstract][Full Text] [Related]
6. The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.
Biagioli M; Carino A; Cipriani S; Francisci D; Marchianò S; Scarpelli P; Sorcini D; Zampella A; Fiorucci S
J Immunol; 2017 Jul; 199(2):718-733. PubMed ID: 28607110
[TBL] [Abstract][Full Text] [Related]
7. The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction.
Schwabl P; Hambruch E; Seeland BA; Hayden H; Wagner M; Garnys L; Strobel B; Schubert TL; Riedl F; Mitteregger D; Burnet M; Starlinger P; Oberhuber G; Deuschle U; Rohr-Udilova N; Podesser BK; Peck-Radosavljevic M; Reiberger T; Kremoser C; Trauner M
J Hepatol; 2017 Apr; 66(4):724-733. PubMed ID: 27993716
[TBL] [Abstract][Full Text] [Related]
8. Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice.
Carino A; Cipriani S; Marchianò S; Biagioli M; Scarpelli P; Zampella A; Monti MC; Fiorucci S
Sci Rep; 2017 Oct; 7(1):13689. PubMed ID: 29057935
[TBL] [Abstract][Full Text] [Related]
9. Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation.
Renga B; Mencarelli A; Migliorati M; Distrutti E; Fiorucci S
World J Gastroenterol; 2009 May; 15(17):2097-108. PubMed ID: 19418582
[TBL] [Abstract][Full Text] [Related]
10. The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy.
Carino A; Marchianò S; Biagioli M; Scarpelli P; Bordoni M; Di Giorgio C; Roselli R; Fiorucci C; Monti MC; Distrutti E; Zampella A; Fiorucci S
FASEB J; 2021 Jan; 35(1):e21271. PubMed ID: 33368684
[TBL] [Abstract][Full Text] [Related]
11. The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis.
Fiorucci S; Antonelli E; Mencarelli A; Orlandi S; Renga B; Rizzo G; Distrutti E; Shah V; Morelli A
Hepatology; 2005 Sep; 42(3):539-48. PubMed ID: 16108046
[TBL] [Abstract][Full Text] [Related]
12. The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity.
Biagioli M; Carino A; Fiorucci C; Marchianò S; Di Giorgio C; Bordoni M; Roselli R; Baldoni M; Distrutti E; Zampella A; Fiorucci S
J Immunol; 2020 May; 204(9):2535-2551. PubMed ID: 32213564
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
14. GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis.
Biagioli M; Carino A; Fiorucci C; Marchianò S; Di Giorgio C; Roselli R; Magro M; Distrutti E; Bereshchenko O; Scarpelli P; Zampella A; Fiorucci S
Cell Mol Gastroenterol Hepatol; 2019; 8(3):447-473. PubMed ID: 31226434
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling.
Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Urbani G; Morretta E; Monti MC; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Nov; 1867(11):159218. PubMed ID: 35985473
[TBL] [Abstract][Full Text] [Related]
16. Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease.
Biagioli M; Marchianò S; Di Giorgio C; Bordoni M; Urbani G; Bellini R; Massa C; Sami Ullah Khan R; Roselli R; Chiara Monti M; Morretta E; Giordano A; Vellecco V; Bucci M; Jilani Iqbal A; Saviano A; Ab Mansour A; Ricci P; Distrutti E; Zampella A; Cieri E; Cirino G; Fiorucci S
Biochem Pharmacol; 2023 Dec; 218():115900. PubMed ID: 37926268
[TBL] [Abstract][Full Text] [Related]
17. Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats.
Verbeke L; Farre R; Trebicka J; Komuta M; Roskams T; Klein S; Elst IV; Windmolders P; Vanuytsel T; Nevens F; Laleman W
Hepatology; 2014 Jun; 59(6):2286-98. PubMed ID: 24259407
[TBL] [Abstract][Full Text] [Related]
18. Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease.
Marchianò S; Biagioli M; Bordoni M; Morretta E; Di Giorgio C; Vellecco V; Roselli R; Bellini R; Massa C; Cari L; Urbani G; Ricci P; Monti MC; Giordano A; Brancaleone V; Bucci M; Zampella A; Distrutti E; Cieri E; Cirino G; Fiorucci S
J Am Heart Assoc; 2023 Dec; 12(23):e031241. PubMed ID: 37996988
[TBL] [Abstract][Full Text] [Related]
19. The G Protein-Coupled Bile Acid Receptor TGR5 (Gpbar1) Modulates Endothelin-1 Signaling in Liver.
Klindt C; Reich M; Hellwig B; Stindt J; Rahnenführer J; Hengstler JG; Köhrer K; Schoonjans K; Häussinger D; Keitel V
Cells; 2019 Nov; 8(11):. PubMed ID: 31752395
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH.
Carino A; Biagioli M; Marchianò S; Fiorucci C; Zampella A; Monti MC; Scarpelli P; Ricci P; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1422-1437. PubMed ID: 31325638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
